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Microengineered systems provide an in vitro strategy to explore the variability of individual
patient response to tissue engineering products, since they prefer the use of primary
cell sources representing the phenotype variability. Traditional in vitro systems already
showed that primary human osteoblasts embedded in a 3D fibrous collagen matrix
differentiate into osteocytes under specific conditions. Here, we hypothesized that
translating this environment to the organ-on-a-chip scale creates a minimal functional
unit to recapitulate osteoblast maturation toward osteocytes and matrix mineralization.
Primary human osteoblasts were seeded in a type I collagen hydrogel, to establish the
role of lower (2.5 × 105 cells/ml) and higher (1 × 106 cells/ml) cell density on their
differentiation into osteocytes. A custom semi-automatic image analysis software was
used to extract quantitative data on cellular morphology from brightfield images. The
results are showing that cells cultured at a high density increase dendrite length over
time, stop proliferating, exhibit dendritic morphology, upregulate alkaline phosphatase
(ALP) activity, and express the osteocyte marker dental matrix protein 1 (DMP1). On
the contrary, cells cultured at lower density proliferate over time, do not upregulate
ALP and express the osteoblast marker bone sialoprotein 2 (BSP2) at all timepoints.
Our work reveals that microengineered systems create unique conditions to capture
the major aspects of osteoblast differentiation into osteocytes with a limited number of
cells. We propose that the microengineered approach is a functional strategy to create
a patient-specific bone tissue model and investigate the individual osteogenic potential
of the patient bone cells.
Keywords: bone-on-a-chip, osteoblast differentiation, microfluidics, osteocyte, primary human cells, dendrite
formation, in vitro bone model
1. INTRODUCTION
The comprehension of biological mechanisms in bones has a pivotal role in the development of
successful clinical treatments. The developing field of bone engineering aims to take advantage
of the innate repair capacity of this tissue (O’Brien, 2011), but the variability in the outcome
of the products is one of the main limitations for their clinical translation. For example, the
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individual heterogeneous response in newly formed bone tissue
formation leads to drastic changes in the scaffold design
(Reznikov et al., 2019). In vitro models can explore the impact
of individual response in tissue engineering products, but they
require a bone cell source representing the phenotype variability.
Osteoblasts experiencemarked transitional stages during bone
formation, involving changes in cell morphology and gene
expression. Osteoblasts express ALP to provide phosphate ions
and initiate the mineralization process (Chai et al., 2012). They
also secrete osteocalcin (OCN), bone sialoprotein 2 (BSP2),
and osteopontin (OPN) until the end of the mineralization
phase (Franz-Odendaal et al., 2006). When osteoblasts turn to
a more mature phenotype, they reduce ALP expression, become
embedded in a mineralized matrix and form an interconnected
network of osteocytes (Boukhechba et al., 2009). During this
transition, osteoblasts upregulate characteristic proteins as E11
and dentin matrix protein 1 (DMP1) (Atkins et al., 2011).
The expression of sclerostin (Sost gene) is associated with
the final stage of osteocyte differentiation (Bonewald, 2011;
Prideaux et al., 2016). However, osteoblasts can have three other
possible fates but the mechanism regulating this transition is
not clearly understood yet: they can become bone-lining cells
(inactive osteoblasts), undergo apoptosis, or transdifferentiate
into chondroid-depositing cells (Dallas and Bonewald, 2010).
Gene expression profiles (Boukhechba et al., 2009; Sun et al.,
2017) and immunohistochemistry stainings (Uchihashi et al.,
2013; Sun et al., 2015; McGarrigle et al., 2016) in traditional
3D culture systems showed that the expression of osteoblast and
osteocyte markers in vitro corresponded to the in vivo expression
at the same differentiation stages (Franz-Odendaal et al., 2006).
In this context, in vitro bone tissue models are a prerequisite
tool for answering specific questions of cell biology, where
minimal platforms are mandatory for effective research on
human tissue function (Wittkowske et al., 2016; Pirosa et al.,
2018; de Wildt et al., 2019). While traditional tissue engineering
aims to recapitulate whole organs in vitro, organ-on-chip systems
“combines the key features of specific tissue microenvironments
and architecture within a microfabricated device, facilitating
the creation of 3D models that exhibit functional hallmarks
of native tissues” (Zhang et al., 2018). They provide minimal
units mimicking specific features of living organs and human
physiology, as the tissue barrier properties of the human gut and
lung, the parenchymal function of cardiac and hepatic tissue, the
multiorgan interactions between the lymph node and the skin
( Huh et al., 2011; Osaki et al., 2018; Ronaldson-Bouchard and
Vunjak-Novakovic, 2018; Zhang et al., 2018).
Bonemodels on a chip were developed in recent years to reveal
different elements of bone biology, each one based on a critical
advantage of microengineered devices over traditional 2D or 3D
macroscale in vitro systems. For example, the use of optically
transparent materials allowed the monitoring of osteoblast
motility in a confined 3D environment (Movilla et al., 2018). The
results of this study elucidated the effect of ECM degradation
and its architecture on osteoblast migration, by applying growth
factor gradients or interstitial fluid flow (Del Amo et al.,
2018). Moreover, the culture chamber geometries facilitate the
reproduction of 3D organ-level structures. Microengineered
devices highlighted how a 3D microvasculature integrates
with the mineralized bone tissue microenvironment and
enhances osteogenic differentiation of cells in the surrounding
tissue construct (Bertassoni et al., 2014; Jusoh et al., 2015).
Organ function relies on the presence of biomechanical and
biochemical stimuli. Mechanical, electrical, and chemical stimuli
can simultaneously stimulate cells cultured in organ-on-chip
systems (Zhang et al., 2018). The use of compartmentalized
culture environments promotes the selective application of those
stimuli to different cell types. A 2D microfluidic platform with
osteoclasts and osteocytes cultured in separate compartments
was key to observe the cross-talk between mechanically
stimulated osteocytes, osteoclast precursors and unstimulated
osteocytes (You et al., 2008; Middleton et al., 2017). In general,
microfabrication techniques applied to cell biology aims to
develop advanced human disease models by the inclusion of
pathological factors. For example, organ-on-a-chip systems with
an ex vivo decellularized bonematrix or an osteo-cell conditioned
extracellular matrix (ECM) have recreated the interplay between
cancer and endothelial cells with the bone matrix in metastatic
colonization (Bersini et al., 2014; Marturano-Kruik et al., 2018).
Such systems consisted of a bone-like microenvironment
including a monolayer of endothelial cells, which provided the
capacity to obtain quantitative data on the extravasation of
breast cancer cells. They were proposed as an advanced model
to screen novel organ-specific therapeutics, since the osteo-
cell conditioned microenvironment secreted specific chemokines
affecting the extravasation process (Bersini et al., 2014).
Osteocytes are the central regulators of bone homeostasis
in vivo. Their regulatory activity on both processes of
bone formation and resorption relies on the secretion of
specific proteins to interact with osteoblasts and osteoclasts
(Bonewald, 2011). Mature osteocytes are the only bone
cells expressing sclerostin after matrix mineralization, which
suppresses osteoblast activity and inhibits further bone formation
(Poole et al., 2005). On the other hand, the receptor activator
of nuclear factor-kB ligand (RANKL) is a cytokine that
controls osteoclastogenesis and has a fundamental role in bone
remodeling. The expression of RANKL by osteocytes is ten times
higher than by osteoblasts in normalmice and its specific deletion
in osteocytes induces osteopetrosis (Nakashima et al., 2011).
The effect of osteocyte activities to other bone cells is
a vital function that requires advanced in vitro models
to be investigated. Traditional in vitro cultures replicated
essential features of the interaction between osteoblasts
and osteocytes, such as osteoblast maturation and
matrix mineralization. These systems consisted of 3D
collagen hydrogels/sponges and human osteoblast-like cells
(Atkins et al., 2009; Bernhardt et al., 2019; Skottke et al., 2019) or
mouse clonal cell-lines (MC3T3-E1 and IDG-SW3) (Woo et al.,
2011; McGarrigle et al., 2016), with the last ones usually preferred
due to the excessive number of cells required. On a micro-scale, a
2D layer of MC3T3-E1 cells spontaneously formed a mineralized
collagenous matrix in long-term cultures (up to 1 month) (Hao
et al., 2018). Cells were mainly present in the apical and basal
layers of the matrix, possibly due to excessive proliferation of
the mouse cell-line. No previous bone-on-a-chip device has
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 2 April 2020 | Volume 8 | Article 336
Nasello et al. Human Osteoblasts Differentiation in Bone-on-a-Chip
differentiated primary human osteoblasts into osteocytes while
embedded in a 3D extracellular matrix. There is a need for a
novel microengineered model to explore the interaction between
the two cell types.
Microfabricated platforms facilitate the use of cells derived
from patients, thus creating models of human physiology with
higher clinical impact. Primary and mature human cells are
difficult to extract in large amounts, proliferate slowly and tend to
dedifferentiate rapidly. Those systems require a limited amount
of cells and aim to recreate the native microenvironment: they
provide an approach to culture cells representing the variability
of the cell phenotype (Zhang et al., 2018). This is a key
advantage of the organ-on-a-chip over traditional technologies,
considering the growing concern about the use of immortalized
cell-lines for reliable human models (Lorsch et al., 2014). Cell-
lines could lead to different results with respect to primary cells
from the same species. For example, murine early osteocyte
cell-line MLO-A5 created an interconnected 3D network in a
microfluidic perfusion device (Gu et al., 2015) but produced a
highly mineralized and dense tissue compared to primarymurine
bone cells (Sun et al., 2015).
We developed a bone-on-a-chip device to translate the
findings of traditional macro-models on differentiated osteocyte
networks to the scale of micro-devices. We hypothesized that the
combination of primary human cells and a 3D fibrous collagen
matrix in a microengineered platform creates a more robust
model to recapitulate osteoblast maturation toward osteocytes
and matrix mineralization. We developed a 3D cell culture
system where the structural and biochemical microenvironment
induced (1) the mineralization of a collagen matrix and (2) the
differentiation of primary human osteoblasts into osteocytes.
The specific aims were to determine the osteogenic behavior of
osteoblasts embedded in a collagen type I hydrogel in terms of: (1)
cellular morphology, (2) dendrite tracking, (3) cell proliferation,
(4) ALP activity, (5) calcium deposition, and (6) synthesis of
specific osteoblasts and osteocytes markers, respectively, BSP2
and DMP1, as well as the role of cell density in the formation
of a bone tissue model.
2. MATERIALS AND METHODS
2.1. Cell culture
The low quantity needed for bone-on-a-chip experiments and
the stability in the expression of the most critical genes during
in vitro culture (Sun et al., 2017) favored the choice of primary
human osteoblasts (HOBs) for the bone tissue model presented
in this study.
HOBs were purchased from PromoCell (C-12720, Germany).
These cells are fully differentiated osteoblasts isolated from
femoral trabecular bone tissue from the knee or the hip joint
region of healthy single donor. HOBs from two different donors
were used (donor 1: caucasian female 86 years, donor 2:
caucasian male 74 years). Cells were cultured under standard
conditions (5%CO2, 37
◦C), in cell expansionmedium containing
standard Dulbecco’s Modified Eagle Medium (DMEM low
glucose; Thermo Fisher Scientific, MA) supplemented with 10%
fetal bovine serum (FBS; Thermo Fisher Scientific), 100 U/mL
penicillin, 100 µg/mL streptomycin, and 2 mM L-glutamine (all
Lonza, Switzerland). At each passage, cells were washed with
phosphate buffered saline (PBS; Lonza), detachedwith TrypLETM
Express (Invitrogen, CA) and plated in T25 cell culture flasks
(Thermo Fisher Scientific) at a density of 15,000 cells/cm2.
Cells were used at passage 4–7 and mixed to the collagen gel
solution. Final cell densities of 2.5 × 105 (low) and 1 × 106
cells/ml (high) were based on recent findings on osteocyte
differentiation in traditional in vitro systems (McGarrigle et al.,
2016).
Once loaded to the organ-on-a-chip devices, HOBs were
cultured under static conditions in cell osteogenic medium,
containing cell expansion medium supplemented with
50 µM ascorbic acid and 10 mM β-glycerol phosphate
(both Sigma-Aldrich). Those supplements are widely
accepted to induce osteogenic differentiation of stem
cells in vitro and deposition of mineralized extracellular
matrix (Langenbach and Handschel, 2013).
2.2. Bone-on-a-Chip System
Bone-on-a-chip devices were fabricated in
poly(dimethlysiloxane) (PDMS) by soft lithography, following
the methodology described by Shin et al. (2012).A commercial
product was used to produce the silicone elastomer (Sylgard
184 Silicone Elastomer Kit, Dow Chemical, Germany), which
comprises a polymeric base and a silicone resin solution as
curing agent. The two liquid parts were mixed in a 10 (base)
:1 (curing agent) ratio and poured in a master made of SU-8
where the microengineered geometry was patterned with a
photolithography technique. The masters were then placed in
a vacuum desiccator for one hour, to remove air bubbles in the
PDMS solution, and kept in a dry oven overnight to cure the
mixture. Later, dermal biopsy punches were used to create the
reservoirs for cell culture media and the hydrogel inlets to the
culture chamber (Figure 1A). PDMS devices followed a wet
and a dry autoclave cycle before being bonded to a 35 mm glass
(Ibidi, Germany) by plasma treatment (PDC-32G Basic Plasma
Cleaner, Harrick Plasma, NY, USA) under vacuum conditions
(Figure 1B). They were then coated with PDL (poly-D-lysine; 1
mg/ml in phosphate buffered saline; Sigma-Aldrich, Germany)
and washed after 4 h to enhance matrix adhesion. Before use,
the devices were left in a dry oven at 80◦C for 48 h to restore the
hydrophobicity of the bonded surfaces (Shin et al., 2012).
A previously developed geometry that consists of a central
culture chamber divided into three compartments was selected
for this study (Del Amo et al., 2017). Briefly, the length of a
single compartment was 2.5 mm, the width was 1.145 mm,
and the average height was 290 µm (Figure 1A). The chip uses
equally spaced (175µm) trapezoidal columns to separate the
compartments and support the hydrogel via surface tension: gel
contraction occurs only on the lateral channels while the 3D
culture environment is maintained in the central channel during
the whole experiment.
Cell laden collagen hydrogels, with a final collagen
concentration of 6 mg/ml, were prepared by mixing in an
ice bath collagen type I solution (Rat Tail; 8.9 mg/ml; Corning,
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FIGURE 1 | Geometry of the bone-on-a-chip system. (A) 2D top view of the bone-on-a-chip system and detail of the culture chamber divided into three
compartments by trapezoidal columns. The cell laden collagen hydrogels (purple) were loaded through the central compartment, while cell culture media (pink) was
provided through the lateral channels. The height of the culture chamber is 290 ± 20 µm. (B) Picture of the bone-on-a-chip system bonded to a 35 mm glass.
NY), 10x Dulbecco’s phosphate buffered saline (DPBS; Sigma-
Aldrich), 0.5 M NaOH (Sigma-Aldrich) to adjust the pH to
7.4–7.6, and human osteoblasts suspended in cell expansion
medium. After gently pipetting the solution into the culture
chamber, it polymerized for 20 min in a humid chamber at 37◦C.
The temperature and the pH conditions mentioned
above induced a self-assembled gelation process of
the collagen hydrogels, where collagen fibers are
physically crosslinked (Chuang et al., 2018). During
the polymerization process, collagen fibers create an
interpenetrating polymer network in presence of living
cells (Rowe and Stegemann, 2006). The microarchitecture and
the mechanical properties of the collagen fibrous hydrogels
used in this study were characterized in previous studies
(Moreno-Arotzena et al., 2015; Del Amo et al., 2018). In the
present work, we selected the 6 mg/ml gel because its Young
modulus (∼0.72 kPa, from Valero et al., 2018) was comparable to
the one (∼0.58 kPa) that allowed a homogeneous cell distribution
in a 3D matrix and enhanced osteocytic differentiation of
MC3T3-E1 cells (McGarrigle et al., 2016).
2.3. Phalloidin and DAPI Fluorescence
Staining
Morphological analysis of cell phenotype is commonly used to
assess osteoblast-osteocyte differentiation (Mullen et al., 2013).
Cells were fixed after 21 days of culture using 4% (w/v)
paraformaldehyde (PFA, Thermo Fisher Scientific) for 30 min,
blocked overnight in PBS with 5% bovine serum albumin
(BSA) and incubated overnight with Phalloidin-TRITC (0.1
mg/ml in PBS, Sigma Aldrich) and DAPI (0.01 mg/ml in PBS,
Invitrogen). Samples were observed with a confocal microscope
(Zeiss LSM880, Zeiss, Germany). Maximum intensity and 3D
volumetric images were generated from z-stacks using ImageJ
software (v 1.49, NIH).
2.4. Cell Dendrite Tracking
Brightfield images of the same samples were taken to track
changes in dendrite morphology. Devices were observed at 10x
and 20x magnification over the 21 days of culture with an
inverted brightfield microscope (Nikon D-Eclipse C1, Japan) and
focused in the middle of the culture chamber. Z-stacks were
obtained with a distance of 5 µm between each slice and for a
maximum thickness of 100 µm. A minimum number of 3 stacks
were taken for each cell density at each timepoint.
A custom semi-automatic image analysis software was
developed with Python programming language to track cell
dendrite length over time. Original z-stacks images were opened
with the Bio-format software tool (Linkert et al., 2010) and
processed with the scikit-image library (van der Walt et al.,
2014). After cells were manually contoured, an automatic
algorithm computed the medial axis transform of the binary
cell mask. An Otsu’s thresholding algorithm later separated the
cell body primary and secondary dendrites from the cell body.
The software quantified the length of cell primary protrusions,
defined as the longest branches starting from the cell body, and
detected cell-cell connections if cell boundaries were in the same
image of the z-stack.
Osteocytes exhibit exploratory dendrites that extend and
retract from the surrounding extracellular matrix before forming
a fully developed osteocyte network (McGarrigle et al., 2016).
Cell primary protrusions longer than 10 µm were defined as
dendrites, as previously described (Mullen et al., 2013).
2.5. DNA Content
Osteoblasts move from a proliferative (preosteoblast) to
a quiescent phase (mature osteoblasts/osteocytes) during
differentiation (Franz-Odendaal et al., 2006). Thus, DNA
content was measured using the Hoechst 33,258 DNA assay
to monitor cell proliferation over time. Cells were isolated
by digesting the collagen matrix overnight in a solution of
collagenase from Clostridium histolyticum (Sigma-Aldrich, 2
mg/ml, ≥ 125 CDU/mg) and centrifugating cell suspension
at 13,000 rpm for 15 min. 100 µl of Hoechst buffer [1 mM
EDTA, 10 mM Tris (hydroxymethyl) aminomethane and 0.1 M
Sodium Chloride at pH 7.4, all reagents from Sigma-Aldrich]
was added to the pellet. Cells were lysed by applying 3 cycles
of freezing (−80◦C)-thawing procedure before running the
biochemical assay. Later, 20 µl of cells lysate or DNA standards
were suspended in 200 µl of Hoechst dye solution (0.1% v/v,
Sigma-Aldrich) and added in a 96-well plate in triplicate.
Fluorescence was then measured (excitation: 380 nm; emission:
440 nm) using a fluorescence spectrophotometer (Synergy HT
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Multi-mode microplate reader, BioTek Instruments, VT, USA).
Readings were converted to DNA content using a standard
curve, according to the manufacturer’s protocol, with samples
containing no cells subtracted as background.
2.6. Extracellular ALP Activity
The metalloenzyme ALP initiates the calcification process by
providing inorganic phosphates (Coleman, 1992; Golub and
Boesze-Battaglia, 2007). It is used as a marker for osteoblast
activity, since ALP expression changes over time when osteoblast
differentiation occurs (Atkins et al., 2009). Extracellular ALP
activity was measured using a colorimetric assay of enzyme
activity (SIGMAFAST p-NPP Kit, Sigma Aldrich). It uses p-
nitrophenyl phosphate (pNPP) as colorimetric substrate that
changes absorbance when dephosphorylated by ALP. Cell culture
media was changed and sampled after 2 h at days 3, 7, 14, 21,
and stored at −80◦C. After thawing, 40 µl of medium were
added to a 96-well plate in triplicate with 50 µl of pNPP solution
(Birmingham et al., 2012). Samples were incubated at room
temperature in the dark for 1 h, and absorbance was read at 405
nm with a spectrophotometer. Readings were converted to ALP
production using a standard curve, with samples containing no
ALP subtracted as background. ALP production was normalized
by the DNA content of each sample in order to get comparable
estimations of ALP activity between samples with different initial
cell seeding density.
2.7. Mineralization
Calcein green staining (Sigma Aldrich) was performed to analyze
calcium deposition without affecting cell viability after 7, 14,
and 21 days (Schiavi et al., 2015). Calcein was dissolved in 0.5
M NaOH solution (Sigma Aldrich) at 2.5 mg/ml. After mixing,
the solution was sterilized with a 0.2 µm Nylon filter, wrapped
with aluminum foil and stored at 4◦C. Cells were incubated
with calcein (25 µg/ml in osteogenic media) (Sigma) for 5 days,
washed 3 times in PBS and fixed using 4% (w/v) PFA. Samples
were imaged with a confocal microscope (λex = 470–509 nm) and
maximum intensity images were generated from z-stacks using
ImageJ software.
2.8. Immunofluorescent Staining
BSP2 is a non-collagenous protein upregulated by osteoblasts
during the tissue mineralization and downregulated when
osteocyte differentiation occurs. DMP1 is an extracellular
matrix protein associated with osteocytes. BSP2 and DMP1
immunofluorescent stainings indicate whether cells cultured in
the bone-on-a-chip samples synthetized osteoblast or osteocyte
markers, respectively (Atkins et al., 2009; Dallas and Bonewald,
2010).
Cells were fixed after 7, 14, 21 days of culture using 4%
(w/v) PFA for 30 min and blocked overnight with 5% BSA.
Later, samples were incubated at 4◦C overnight with mouse
monoclonal BSP2 (Santa Cruz Biotechnology, sc-73630, Texas)
or DMP1 (Santa Cruz, sc-73633) antibody at a dilution of
1:100 in PBS with 0.5% BSA. After washing 3 times for 5 min
with PBS, samples were incubated at 4◦C for 6 h with the
relevant secondary antibody (for BSP2, goat anti-mouse Alexa
Fluor R© 555, Molecular Probes, Oregon, A21424; for DMP1, goat
anti-mouse Alexa Fluor R© 633, Molecular Probes, A21052) at a
dilution of 1:50 in PBS with 0.5% BSA. Cell nuclei were then
counterstained with DAPI and samples were observed with a
confocal microscope. Maximum intensity images were generated
from z-stacks using ImageJ software.
2.9. Statistics
All experiments were conducted in technical triplicates (n = 3)
with two independent experiments, by using different donors.
Python programming language was used to run all the
statistical analyses. We used one-way analysis of variance
(ANOVA) for all the biochemical analyses to assess significant
differences between timepoints, followed by pair-wise multiple
comparison procedure (Tukey’s HSD test). Linear regression
models described the variation of dendrite length over time.
Experimental data are presented as mean ± 95% of confidence
interval if not otherwise specified. P-value < 0.05 was
considered significant.
3. RESULTS AND DISCUSSION
Recent advances in mimicking bone with microengineered
platforms are reducing the gap between the tissue and other more
developed organ-on-chip models but, to our knowledge, they did
not reach to show the development of a device with differentiated
osteocytes and a 3D mineralized matrix.
Given that primary human osteoblasts embedded in a 3D
fibrous collagen matrix is an optimal environment to encourage
osteocyte differentiation (Atkins et al., 2009; Woo et al.,
2011; McGarrigle et al., 2016), we hypothesized that the same
environment translated to organ-on-a-chip scale recapitulates
two key in vivo bone properties: osteoblast maturation and
matrix mineralization. To determine the development of mature
bone formation, we investigated the major aspects underlying
osteoblast-osteocyte differentiation: cell morphology variation,
mineralization, and protein synthesis.
3.1. Cells Show Dendritic Morphology
While Increasing Primary Dendrite Length
Over Time
The osteoblast-osteocyte differentiation is a complex
mechanism, still under investigation, with relevant changes
in cell morphology, polarization, cytoplasmic volume,
number of cell organelles, proliferation, gene expression,
type of collagen deposited, and bone deposition rate.
During these transitional stages, the extension of cellular
dendrites or pseudopodia is the one of most recognizable
variations (Franz-Odendaal et al., 2006).
To observe this morphological change, we stained actin
filaments at the latest timepoint (21 days) and we qualitatively
observed that cells at high density exhibited a dendritic
morphology as well as initial interconnections. On the other
hand, cells at low density kept an aligned morphology with a
limited amount of dendrites (Figure 2).
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FIGURE 2 | Cells cultured at high density show dendritic morphology.
Representative confocal images of cell nuclei (DAPI) and actin filaments
(phalloidin) after 21 days of culture in bone-on-a-chip samples at high and low
cell density. Scale bar, 50 µm.
Osteoblasts were already classified with a spread, aligned,
transitional, or dendritic morphology during their differentiation
into osteocytes in vitro (Mullen et al., 2013), and mineralizing
conditions enhanced the development of a stellate morphology
(Atkins et al., 2009). Microfluidics showed that pre-osteoblastic
mouse cells adhere and spread differently along a stiffness
gradient, but it did not highlight any morphological variation
(Almodóvar et al., 2013). Here, the difference in cell shape
suggests that human osteoblasts cultured at 1 × 106 cells/ml
(high density) are more differentiated into osteocytes than cells
cultured at 2.5 × 105 cells/ml (low density) (Figure 2). The
dendritic morphology for the high density group reported here
is consistent with the results in a traditional 3D in vitro systems,
where mouse bone cells cultured at a low cell density (2.5 × 105
cells/ml) had a lower percentage of dendritic cells with respect
to cells cultured at high density (2 × 106 cells/ml) (McGarrigle
et al., 2016). Dendritic protrusions of primary human osteoblasts
in collagen hydrogels is documented in the literature for
initial cell seeding densities lower than 2.5 × 105 cells/ml
(Atkins et al., 2009; Bernhardt et al., 2019; Skottke et al., 2019
In these cases, the maximum collagen concentration in the
hydrogel was 3 mg/ml, which is half of the 6 mg/ml used
in our study. Hydrogels with lower collagen concentration
have lower mechanical properties (Chuang et al., 2018), which
favor a dendritic cell morphology even at lower cell seeding
densities (McGarrigle et al., 2016). Osteoblast differentiation was
reduced in hydrogels with low collagen concentration when
they were modified with biomimetically or strontium-doped
mineralized collagen, confirming that the higher stiffness of the
matrix delays the differentiation for low cell seeding densities
(Bernhardt et al., 2019). On the other hand, hydrogel contraction
limits the use of high cell seeding densities. Our bone-on-a-chip
system, where trapezoidal columns within the culture chamber
reduces the hydrogel contraction, facilitated the use of hydrogels
with higher collagen concentration, thus favoring the culture of
cells at higher seeding densities and the exhibition of a dendritic
morphology at higher collagen concentrations.
Experimental biology requires novel automatic tools for
image analysis to support the conversion of microscopy images
into quantitative data (Eliceiri et al., 2012). To demonstrate a
consistent change in cellular morphology, a customed image
analysis software was developed to automatically separate cell
body from dendrites, after amanual selection of the cell boundary
(Figure 3B). The software quantified the cell dendrite length and
detected cell-cell connections of cells in the same image of the
z-stack (Figure S1, Video S1).
Cells cultured at high density experiences a significant
dendrite growth of 1.01 ± 0.25 µm/day (Figure 3C) over the
whole period of culture, confirming osteoblast change to a
dendritic morphology compared to the lower density.
Cells cultured at low density did not increase dendrite length
over time (Figure 3C). This analysis did not show a quantitative
change in cell morphology for the low density group, as suggested
by the aligned shape observed in confocal imaging (Figure 2).
Compared to traditional in vitro culture, the ratio between
the volumes of culture and the fewer number of cells used
in microengineered devices make quantitative image analyses
more representative of the whole cell population present in each
sample. The number of cells tracked in this study (n ≈ 50 cells
per timepoint) is 100 times lower than the total amount of cells
in our samples (≈5,000 cells), while in traditional systems it
is usually 1,000,000 times lower. Moreover, the high control of
the geometries of the organ-on-a-chip culture chamber allows
the identification of the same image location at each timepoint.
The combination of the organ-on-chip technology with a semi-
automatic software that decreases operator-dependent errors
produce a more accurate and reliable platform for quantitative
image analysis.
The evaluation of cell-cell connections showed a limited
variation over time, due to the requirement for cell boundaries
to be on the same image of the z-stack (Video S1). However, we
observed a slight increase in cell connections for cells cultured
at high density over time (Figure 3A). Osteoblasts did not
form an interconnected network, they rather showed exploratory
dendrites to create transient connections and position themselves
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FIGURE 3 | Cells cultured at high density increase primary dendrite length over time. (A) Brightfield images of cultured human osteoblasts with superimposed
tracking. Scale bar = 150 µm. (B) Cell image detail. Identification of the cell body, contour, primary dendrites, and connection with a semi-automatic algorithm. (C)
Primary dendrite length measured with a customed software for dendrite tracking. Linear regression model in dashed lines (n ≈ 50 cells per timepoint). Data are mean
±95% c.i.
in the extracellular matrix (Zhang et al., 2006; McGarrigle et al.,
2016). The dendritic morphology at the end of the culture and the
increase in exploratory dendrite length indicated that osteoblasts
cultured at high density underwent differentiation into an early
osteocytic phenotype.
3.2. Alkaline Phosphatase (ALP)
Upregulation Is Associated With the
Interruption of Cell Proliferation
The cessation of cell proliferation and collagen matrix
production follows the secretion of soft osteoid that surrounds
osteoblasts initiating differentiation (Atkins et al., 2011). To
determine whether the culture microenvironment regulated
cell proliferation in our bone-on-a-chip, we degraded the 3D
collagen matrix, extracted cells and quantified the evolution of
the DNA content.
DNA content had a negative trend over time for the high
cell density group, as suggested by the lower DNA content
at day 14 compared to day 3 (Figure 4). The amount of
DNA measured from a unique cell type is proportional to the
total number of cells. Thus, osteoblasts were not proliferating
in our bone-on-a-chip system, plausibly because they were
undergoing a differentiation process. Only a limited proportion
of osteoblasts differentiates into osteocyte in vivowhile the rest of
the population follows other fates, including apoptosis (Franz-
Odendaal et al., 2006). If cells seeded at high density were
differentiating into osteocytes, the decreasing trend in the DNA
amount confirmed that our microenvironment also induced the
apoptosis of a subpart of the osteoblast population.
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FIGURE 4 | Cells cultured at low density proliferate over time. DNA content of
each group at day 3, 7, 14, and 21. Point plots denote the mean of n = 6
samples with error bars representing 95% of confidence interval. *Represents
statistical significance (p < 0.05) between indicated groups using one-way
ANOVA with Tukey’s post-hoc test.
A 3D culture environment made of a microbeads assembly
already showed that osteoblastic cells cultured in a microfluidic
system stop proliferating, compared to a control group cultured
in a plate where cells were proliferating. The cell number
quantification in the microbead assembly was estimated by the
ratio of the number of cells and the number of microbeads
imaged (Sun et al., 2017). Here, we developed a protocol to get
a more direct measure of the amount of cells over time in the
microengineered sample.
In the low cell density group, by day 21 the DNA content was
significantly higher than early timepoints (Figure 4), suggesting
that cells started proliferating under these culture conditions.
Our results show that after an initial period of quiescence,
osteoblasts seeded at low density maintained their proliferative
capacity in our bone-on-a-chip, supporting the hypothesis
that they were not differentiating into osteocytes. The use
of primary human cells was crucial to capture the difference
between proliferative and non-proliferative conditions in the
bone-on-a-chip model. Cell-lines have high proliferation rates
which make them not very suitable to study this precise
aspect of bone cells function (Clover and Gowen, 1994). For
example, a mouse osteoblast cell-line (MC3T3-E1) showed to
proliferate even if cells were differentiating into osteocytes
and creating an interconnected network between dendritic
cells (McGarrigle et al., 2016). The combination of primary
human cells and microengineered technology give a valid
solution to culture cells representative of the in vivo phenotype
maximizing the number of samples. Such system is a unique
representative model of osteoblast proliferation in a physiologic
3D environment.
The transition from a proliferative to a quiescent phase during
osteoblast differentiation is concomitant to the upregulation of
ALP and its later reduction (Boukhechba et al., 2009). To assess
osteoblast secretion of ALP during culture, we quantified the
evolution of enzyme activity in the culture media and the effect
of cell density.
Extracellular ALP activity was normalized by the DNA
content and showed an upregulation for the high density group
compared to the low density in both donors (Figure 5). The
ALP activity had increasing trend for cells cultured at high
density, even if the magnitudes of the ALP measurements
were higher for donor 2 compared to the donor 1. Moreover,
cells from the donor 1 showed a significantly higher ALP
activity by day 7 followed by a decreasing trend (Figure 5A).
Differences in trends of the ALP measurements might be
related to inter-donor variability, and more specifically to
the differences in age and sex between donors. Cells from
the younger male donor (donor 2) had higher absolute ALP
activity and didn’t show the trend observed in donor 1.
However, the upregulation of ALP activity for cells cultured
at higher density confirmed the higher potential for matrix
mineralization and osteogenic differentiation for both donors. In
tissue engineering, the upregulation of ALP expression relates
to osteogenesis and is a precursor to mineralization of the
tissue (Golub and Boesze-Battaglia, 2007). Previous studies in
microfluidic devices only showed the upregulation of ALP
activity at the end of the culture, proving that those platforms
promoted osteogenesis (Leclerc et al., 2006; Jang et al., 2008;
Hao et al., 2018). Here, we measured the temporal evolution
of ALP activity during the whole culture and it suggested that
osteoblasts cultured at high density had a phase of increase of
mineralization in the first week of culture and later continued the
differentiation process.
Calcein is a fluorochrome binding calcium at bone
mineralization front (Yeh et al., 2018), thus identifying
newly mineralized matrix. Calcium staining with calcein at
days 7, 14, and 21 showed that primary human osteoblasts
mineralized the extracellular matrix over the whole period
of culture. Images qualitatively confirmed the results of
ALP activity, with a higher presence of calcium ions for
the cells cultured at high density (Figure S2). Our results
suggest that the low cell density tested (2.5 × 105 cells/ml)
was insufficient to initiate osteoblasts differentiation in this
hydrogel and they needed to proliferate more before undertaking
this pathway.
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FIGURE 5 | Cells cultured at high density upregulate alkaline phosphatase (ALP) activity. Extracellular ALP activity of each group at day 3, 7, 14, and 21. Point plots
denote the mean of n = 3 samples (row A—donor 1, row B—donor 2) with error bars representing 95% of confidence interval. *Represents statistical significance (p <
0.05) between indicated groups using one-way ANOVA with Tukey’s post-hoc test.
3.3. Cell Density Regulates
Osteoblast/Osteocyte Marker Synthesis
Osteoblasts transitional stages during bone formation involve
changes in cell morphology and protein synthesis. As we found
differences in cell morphology, protrusion length dynamics,
proliferation, and osteogenesis, we investigated the qualitative
expression of bone matrix proteins. We selected two specific
proteins BSP2 and DMP1, representative of osteoblast and
osteocyte phenotype respectively, to determine the effect of cell
density on their production.
Immunofluorescent staining for BSP2 demonstrated positive
synthesis within the proximity of cells in the earliest days
of culture for both cell density groups, confirming the initial
osteoblast phenotype of the cells used at the beginning of
the experiment. Osteoblasts cultured at low density produced
BSP2 at all timepoints (Figure 6), suggesting that no transition
to osteocyte occurred for this group. On the contrary, the
high density group reduced BSP2 expression at the end
of the culture (21 days, Figure 6). The lower presence of
BSP2 denoted that cells cultured at high density group
changed differentiation stage in the bone-on-a-chip devices.
BSP2 expression is characteristic of osteoblast phenotype, even
if it was observed in lower amounts in osteocytes (Franz-
Odendaal et al., 2006). Another osteocytic marker needs to
determine whether cells of the high density group underwent this
specific fate.
Low presence of DMP1 staining were observed for cells
cultured at low density (Figure 7), supporting that cells of this
group experienced a limited transition into the osteocyte stage
during the whole culture period. DMP1 was more expressed by
the human osteoblasts cultured at high density at all timepoints
(Figure 7). The faster osteoblasts transition to osteocytes was
confirmed by the presence of this osteocytic marker, together
with the decreased presence of the osteoblast marker BSP2
(Figure 6). The positive DMP1 staining for cells cultured at high
density reported here is consistent with the results in a traditional
3D in vitro systems, where cells cultured at higher density (2×106
cells/ml) produced more DMP1 as dispersed nodules within the
surrounding matrix (McGarrigle et al., 2016).
3.4. Cells Cultured at Higher Density
Differentiate Faster Into Osteocytes
Overall, our data showed how the 3D microenvironment in our
bone-on-a-chip regulated osteoblast-osteocyte differentiation
(Figure 8). The microengineered technology created a highly
controllable environment to study the maturation of primary
human bone cells in a 3D extracellular matrix made of
the most abundant organic component in bone tissue. A
custom semi-automatic image analysis software led to the
extraction of quantitative data on the cellular morphology from
microscopy images. In addition, the use of primary human
cells at high cell density was crucial to mimic the physiological
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FIGURE 6 | Cells cultured at low density synthesize bone sialoprotein 2 (BSP2) at all timepoints. Representative confocal images of cell nuclei (DAPI), calcium ions
(calcein), and BSP2 in bone-on-a-chip samples cultured at high and low cell density. Scale bar, 30 µm.
FIGURE 7 | Cells cultured at high density synthesize dental matrix protein 1 (DMP1). Representative confocal images of cell nuclei (DAPI), calcium ions (calcein), and
DMP1 in bone-on-a-chip samples cultured at high and low cell density. Scale bar, 30 µm.
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FIGURE 8 | Bone-on-a-chip development with two cell seeding densities. Primary human osteoblasts were encapsulated in type I collagen hydrogel (purple in the
figure) at 2.5× 105 (low cell density) and 1× 106 (high cell density) cells/ml, then loaded in the bone-on-a-chip devices and cultured up to 21 days to study matrix
mineralization and cell differentiation into osteocytes. Cell morphology, dendrite tracking, DNA content, alkaline phosphatase (ALP) production, calcium deposition
(white in the figure), and immunofluorescent staining of bone sialoprotein 2 (BSP2, yellow in the figure) and dentin matrix protein 1 (DMP1, green in the figure) were
performed to assess the osteogenic phenotype of the cells. At low cell density, the biochemical 3D microenvironment induced only the expression of osteoblast
markers (ALP, BSP2). While the change in cell morphology, the upregulation of ALP and the expression of DMP1 suggested that osteoblast transition to osteocytes
occurred faster for cells cultured at high density.
shift from proliferative to non-proliferative conditions during
the differentiation process. The expression of characteristics
osteoblast and osteocyte markers confirmed differentiation
with changes in synthesis of extracellular matrix proteins.
Furthermore, by 21 days of in vitro culture, osteoblasts cultured at
high density increased the protrusion length over time, exhibited
dendritic morphology, did not increase cell number, upregulated
ALP activity, downregulated BSP2 synthesis and produced more
DMP1. Thus they underwent changes in cell morphology,
proliferation, mineral deposition and protein production that
are specific of the differentiation into osteocytes. Conversely,
osteoblasts cultured at low density had constant protrusion
length up to 21 days, proliferated, had constant ALP activity and
produced only BSP2. They consistently exhibited no transition
toward the osteocytic phenotype.
One limitation of this study is the presence of a 3D
hydrogel embedding cells in a narrow space that made RNA
purification not possible after extraction for gene expression
analysis. Moreover, the cell extraction protocol took one night
for the complete digestion of the collagen matrix, which would
inexorably affect results from PCR. Previous works on cell
differentiation in microfluidic systems focused on the protein
expression rather than gene profiles (Kim et al., 2011; Li et al.,
2014; Park et al., 2015; Zhang et al., 2015; Agrawal et al.,
2017), considering the technical challenges and that protein
biosynthesis depends on transcript levels as well as other
factors such as the local availability of resources (Liu et al., 2016).
We believe that our results on dendritic morphology, cell
proliferation, alkaline phsphatase activity and protein synthesis
firmly indicate osteoblasts differentiation and the effectiveness of
the microengineered technology used.
4. CONCLUSIONS
Traditional in vitro systems already showed that primary
human osteoblasts embedded in a 3D fibrous collagen matrix
differentiates into osteocytes under specific conditions. Here,
we translated the findings of traditional macro-models on
osteoblast differentiation to the organ-on-a-chip scale. We
created a minimal functional unit that captures the major aspects
underlying the differentiation of primary human osteoblasts
into osteocytes, which depends on the cell seeding density.
A custom image analysis software was developed to support
the semi-automatic analysis of cell dendrite elongation. Only
the human osteoblasts seeded at higher density underwent the
change in cell morphology, proliferation, mineral deposition
and protein synthesis that are specific of the differentiation
into osteocytes. The use of the microengineered technology
to study the maturation of primary human osteoblasts in a
3D fibrous extracellular matrix takes advantage of the limited
number of cells required by these systems, creating a unique
platform to represent the phenotype variability as well as to
elucidate the role of single or simultaneous stimulation in
osteoblast maturation. From a clinical perspective, the bone-on-
a-chip presented in this work provides the minimal functional
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microenvironment to build patient-specific bone models to
study the individual osteogenic potential and the effect of
alternative therapies.
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